{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T13:21:28Z","timestamp":1776259288984,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T00:00:00Z","timestamp":1768608000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T00:00:00Z","timestamp":1768608000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1245\/s10434-025-19043-5","type":"journal-article","created":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T17:34:50Z","timestamp":1768671290000},"page":"4153-4160","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Raised Serum Tumour Markers Predict Incomplete Cytoreduction, Disease-Free and Overall Survival in Patients with Colorectal Peritoneal Metastases Treated by Cytoreductive Surgery and HIPEC"],"prefix":"10.1245","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5019-7305","authenticated-orcid":false,"given":"Niccolo","family":"Allievi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Bayney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark Vasanth","family":"Samuel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexios","family":"Tzivanakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjeev","family":"Dayal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Cecil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faheez","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brendan","family":"Moran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,17]]},"reference":[{"issue":"9","key":"19043_CR1","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1245\/s10434-008-9966-2","volume":"15","author":"VJ Verwaal","year":"2008","unstructured":"Verwaal VJ, Bruin S, Boot H, Van Slooten G, Van Tinteren H. 8-Year follow-up of randomized trial: Cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol. 2008;15(9):2426\u201332. https:\/\/doi.org\/10.1245\/s10434-008-9966-2.","journal-title":"Ann Surg Oncol."},{"issue":"9","key":"19043_CR2","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1111\/codi.12975","volume":"17","author":"B Moran","year":"2015","unstructured":"Moran B, Cecil T, Chandrakumaran K, Arnold S, Mohamed F, Venkatasubramaniam A. The results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in 1200 patients with peritoneal malignancy. Colorectal Dis. 2015;17(9):772\u20138. https:\/\/doi.org\/10.1111\/codi.12975.","journal-title":"Colorectal Dis."},{"issue":"7","key":"19043_CR3","doi-asserted-by":"publisher","first-page":"4444","DOI":"10.1245\/s10434-023-13279-9","volume":"30","author":"F Schell","year":"2023","unstructured":"Schell F, Kefleyesus A, Benzerdjeb N, et al. Influence of extraperitoneal metastases on the curative-intent management of colorectal peritoneal metastases. Ann Surg Oncol. 2023;30(7):4444\u201354. https:\/\/doi.org\/10.1245\/s10434-023-13279-9.","journal-title":"Ann Surg Oncol."},{"issue":"13","key":"19043_CR4","doi-asserted-by":"publisher","first-page":"8585","DOI":"10.1245\/s10434-024-15942-1","volume":"31","author":"N Allievi","year":"2024","unstructured":"Allievi N, Sidhom M, Samuel MV, et al. Survival analysis and recurrence patterns in 555 patients with colorectal peritoneal metastases treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2024;31(13):8585\u201395. https:\/\/doi.org\/10.1245\/s10434-024-15942-1.","journal-title":"Ann Surg Oncol."},{"issue":"5","key":"19043_CR5","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.ejso.2013.12.021","volume":"40","author":"P Taflampas","year":"2014","unstructured":"Taflampas P, Dayal S, Chandrakumaran K, Mohamed F, Cecil TD, Moran BJ. Pre-operative tumour marker status predicts recurrence and survival after complete cytoreduction and hyperthermic intraperitoneal chemotherapy for appendiceal pseudomyxoma peritonei: Analysis of 519 patients. Eur J Surg Oncol. 2014;40(5):515\u201320. https:\/\/doi.org\/10.1016\/j.ejso.2013.12.021.","journal-title":"Eur J Surg Oncol."},{"issue":"3","key":"19043_CR6","first-page":"1041","volume":"36","author":"YR Huo","year":"2016","unstructured":"Huo YR, Huang Y, Liauw W, Zhao J, Morris D. Prognostic value of carcinoembryonic antigen (CEA), AFP, CA19-9 and CA 125 for patients with colorectal cancer with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Anticancer Res. 2016;36(3):1041\u20139.","journal-title":"Anticancer Res."},{"issue":"2","key":"19043_CR7","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.0260","volume":"7","author":"A Yousef","year":"2024","unstructured":"Yousef A, Yousef M, Zeineddine MA, et al. Serum tumor markers and outcomes in patients with appendiceal adenocarcinoma. JAMA Netw Open. 2024;7(2):e240260. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.0260.","journal-title":"JAMA Netw Open."},{"issue":"3\u20134","key":"19043_CR8","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s10555-013-9444-6","volume":"32","author":"N Beauchemin","year":"2013","unstructured":"Beauchemin N, Arabzadeh A. Carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) in cancer progression and metastasis. Cancer Metastasis Rev. 2013;32(3\u20134):643\u201371. https:\/\/doi.org\/10.1007\/s10555-013-9444-6.","journal-title":"Cancer Metastasis Rev."},{"issue":"3","key":"19043_CR9","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1001\/jamaoncol.2017.4420","volume":"4","author":"T Konishi","year":"2018","unstructured":"Konishi T, Shimada Y, Hsu M, et al. Association of preoperative and postoperative serum carcinoembryonic antigen and colon cancer outcome. JAMA Oncol. 2018;4(3):309. https:\/\/doi.org\/10.1001\/jamaoncol.2017.4420.","journal-title":"JAMA Oncol."},{"issue":"10","key":"19043_CR10","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.annonc.2020.06.022","volume":"31","author":"G Argil\u00e9s","year":"2020","unstructured":"Argil\u00e9s G, Tabernero J, Labianca R, et al. Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020;31(10):1291\u2013305. https:\/\/doi.org\/10.1016\/j.annonc.2020.06.022.","journal-title":"Ann Oncol."},{"issue":"4","key":"19043_CR11","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1159\/000101952","volume":"39","author":"JY Wang","year":"2007","unstructured":"Wang JY, Lu CY, Chu KS, et al. Prognostic significance of pre- and postoperative serum carcinoembryonic antigen levels in patients with colorectal cancer. Eur Surg Res. 2007;39(4):245\u201350. https:\/\/doi.org\/10.1159\/000101952.","journal-title":"Eur Surg Res."},{"issue":"5","key":"19043_CR12","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1172\/JCI110380","volume":"68","author":"RC Bast","year":"1981","unstructured":"Bast RC, Feeney M, Lazarus H, Nadler LM, Colvin RB, Knapp RC. Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest. 1981;68(5):1331\u20137. https:\/\/doi.org\/10.1172\/JCI110380.","journal-title":"J Clin Invest."},{"issue":"10","key":"19043_CR13","doi-asserted-by":"publisher","first-page":"9190","DOI":"10.1074\/jbc.M312372200","volume":"279","author":"A Rump","year":"2004","unstructured":"Rump A, Morikawa Y, Tanaka M, et al. Binding of ovarian cancer antigen CA 125\/MUC16 to mesothelin mediates cell adhesion. J Biol Chem. 2004;279(10):9190\u20138. https:\/\/doi.org\/10.1074\/jbc.M312372200.","journal-title":"J Biol Chem."},{"issue":"1","key":"19043_CR14","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1476-4598-5-50","volume":"5","author":"JA Gubbels","year":"2006","unstructured":"Gubbels JA, Belisle J, Onda M, et al. Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors. Mol Cancer. 2006;5(1):50. https:\/\/doi.org\/10.1186\/1476-4598-5-50.","journal-title":"Mol Cancer."},{"issue":"6","key":"19043_CR15","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1093\/oxfordjournals.annonc.a059248","volume":"6","author":"A Webb","year":"1995","unstructured":"Webb A, Scott-Mackie P, Cunningham D, et al. The prognostic value of CEA, \u03b2HCG, AFP, CA 125, CA19-9 and C-erb B-2, (\u03b2HCG immunohistochemistry in advanced colorectal cancer. Ann Oncol. 1995;6(6):581\u20137. https:\/\/doi.org\/10.1093\/oxfordjournals.annonc.a059248.","journal-title":"Ann Oncol."},{"issue":"43","key":"19043_CR16","first-page":"160","volume":"49","author":"WS Wang","year":"2002","unstructured":"Wang WS, Lin JK, Chiou TJ, et al. CA19-9 as the most significant prognostic indicator of metastatic colorectal cancer. Hepatogastroenterology. 2002;49(43):160\u20134.","journal-title":"Hepatogastroenterology."},{"issue":"11","key":"19043_CR17","doi-asserted-by":"publisher","first-page":"e0188139","DOI":"10.1371\/journal.pone.0188139","volume":"12","author":"Z Yu","year":"2017","unstructured":"Yu Z, Chen Z, Wu J, Li Z, Wu Y. Prognostic value of pretreatment serum carbohydrate antigen 19\u20139 level in patients with colorectal cancer: a meta-analysis. Plos One. 2017;12(11):e0188139.","journal-title":"Plos One."},{"issue":"6","key":"19043_CR18","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1097\/SLA.0b013e318254f281","volume":"256","author":"PH Cashin","year":"2012","unstructured":"Cashin PH, Graf W, Nygren P, Mahteme H. Patient selection for cytoreductive surgery in colorectal peritoneal carcinomatosis using serum tumor markers: an observational cohort study. Ann Surg. 2012;256(6):1078\u201383. https:\/\/doi.org\/10.1097\/SLA.0b013e318254f281.","journal-title":"Ann Surg."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-19043-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-19043-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-19043-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T12:27:25Z","timestamp":1776256045000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-19043-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,17]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["19043"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-19043-5","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,17]]},"assertion":[{"value":"15 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}